References
- Benita S. Characterization of drug-loaded poly(d,l-lactide) microspheres. Journal of Pharmaceutical Sciences 1984; 73: 1721–1724
- Benita S., Hoffman A., Donbrow M. Polyacrylate resin (Eudagit Retard) microcapsules as a controlled release drug delivery system—improved non-solvent addition phase separation process. Journal of Microencapsulation 1985; 2: 207
- Chang T. M. S. Semipermeable aqueous microcapsules. Science 1964; 146: 524
- Chang T. M. S. Biodegradable microcapsules containing enzymes, hormones, vaccines and other biologicals. Journal of Bioengineering 1976; 1: 25
- Chang T. M. S. Recent advances in artificial cells with emphasis on biotechnological approaches based on microencapsulation. Microcapsules and nanoparticles in medicine and pharmacy. CRC Press Inc., Boca RatonUSA 1992; 323–339
- Chang T. M. S. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnology Annual Review 1995; 1: 267–293
- Crump B., Wise R., Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983; 26: 784
- Donbrow M. Recent advances in microcapsule delivery systems. Topics in Pharmaceutical Sciences, D. D. Breimer, P. Speiser. Elsevier, Amsterdam 1987; 33
- Donbrow M., Hoffman A., Benita S. Phase separation modulation and aggregation-prevention: mechanism of the non-solvent addition method in the presence and absence of polyisobutylene as additive. Journal of Microencapsulation 1990; 7: 1
- Hoffen G., Lode H., Prinzing C., Borner K., Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy 1985; 27: 375
- Lin S. Y. Influence of coacervation-inducing agents and cooling rates on the preparation and in vitro release of bleomycin hydrochloride microcapsules. Journal of Microencapsulation 1985; 2: 91
- Martinez B., Lairion F., Pena M. B., Di Rocco P., Nacucchio M. C. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres. Journal of Microencapsulation 1997; 14: 155–161
- Owusu-Ababio G. Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model. Journal of Medicinal Microbiology 1995; 43: 368–376
- Senjkovic R., Jalsenjak I. Surface topography of microcapsules and the drug release. Journal of Pharmacy and Pharmacology 1981; 33: 665
- Wong J. P., Cherwonogrodzky J. W., Di Ninno V. L., Delacruz R., Saravolac E. G. Liposome-encapculated ciprofloxacin for the prevention and treatment of infectious diseases caused by intracellar pathogens. Liposomes in Biomedical Applications, P. N. Shek. Harwood Academic Press, Amsterdam, Holland 1995; 105–134
- Zhou M. X., Chang T. M. S. Effects of polylactic acid microcapsules containing prostaglandin on the survival rates of grade 11 coma galactosamine-induced fulminant hepatic failure rats. Journal of Biomaterials, Artificial Cells and Artificial Organs 1987; 15: 549–558
- Zhou M. X., Chang T. M. S. Control release of prostaglandin from polylactic acid microcapsules, microparticles and modified microparticles. Journal of Microencapsulation 1988; 5: 27–36
- Zhou Z., Zhou M., Wang S., Lin F., Shan W. Preparation and evaluation in vitro and in vivo of copolylactic/glycolic acid microspheres containing norethisterone. Biomaterials, Artificial Cells and Immobilization Biotechnology 1993; 21: 71